The IRDAI, after consultation with the Advisory Committee, and with...
Category:
Non-Life
Latest
Govt shortlists 4 candidates for selecting IRDAI’s Member, Distribution
Out of many applicants, who had applied for the job, the Ministry...
ICICI Lombard appoints Priya Deshmukh as Head – Health Products, Operations & Services
ICICI Lombard General Insurance has announced the appointment...
Coronavirus vaccine distribution faces logistics, supply chain challenges
There is no adult vaccination programme in the country except tetanus for pregnant women.
Even immunisation of children had its share of difficulties with many people not vaccinating, he said.
Most vaccines may require at least two doses, possibly the second one to be administered after a certain number of days, which increases difficulties in logistics and supply.
Indian-American doctor identifies possible COVID-19 treatment
Published online in the journal Cell, the research coming from the lab of Dr Thirumala-Devi Kanneganti, an Indian-born researcher working at St. Jude Children’s Research Hospital in Tennessee, identified the drugs after discovering that the hyper inflammatory immune response associated with COVID-19 leads to tissue damage and multi-organ failure in mice by triggering inflammatory cell death pathways
China says carbon trading scheme will cover 2,267 power plants in phase one
Under the scheme, firms are given allowances free of charge based on historical emissions, and have to buy additional permits if they exceed their quota. The total amount they need to buy will account for no more than 20% of their allocation.The quota allocations have been determined based on emissions levels from 2013-2019, but the ministry said the collection of relevant data for last year had been disrupted by the COVID-19 pandemic and by funding issues.
Pvt hospitals charged exorbitant fees for Covid-19 treatment:Par panel
“… Cost of health service delivery increased due to absence of specific guidelines for COVID treatment in private hospitals as a result of which patients were charged exorbitant fees,” the committee noted in the report.
Fisheries sector can attract USD 9 billion investment in 5 years: Official
“Government is targeting investments to the tune of USD 9 billion in the fisheries sector over the next five years,” Union Fisheries Secretary Rajeev Ranjan said at an e- conference of Indian Chamber of Commerce.
The central government has also envisaged to improve the quality of life in coastal communities and diversification of the coastal economy through sustainable livelihood opportunities and inclusive development in an integrated manner, and Rs 750 crore has been allocated toward the same, he said.
Zurich Insurance nears $4 billion deal for MetLife unit
It would also allow MetLife to exit a business in which it faces fierce competition from larger players such as State Farm, GEICO and Progressive Insurance.
Questionable testing may be the reason India’s Covid-19 numbers are down
The result is that India’s Covid-19 cases are likely much higher than the national numbers. Health experts fear new infection waves as the country gathers to celebrate a season of weddings and Hindu festivals amid a smoggy winter in the densely populated north.
Aon develops $70mn in alternative capital capacity to transfer systemic cyber risk
The cover allows for limits of up to USD 70 million and will protect against increasing cyber loss aggregations on re/insurers’ balance sheets. The product is structured to protect the cedent from the effects of catastrophic cyber market losses stemming from events such as self-propagating malware or wiperware, distributed denial of service, a significant cloud outage or certificate revocation.
EU could give conditional nod to Moderna vaccine as early as December
The EU could pay more than $10 billion to buy hundreds of millions of doses of the vaccine jointly developed by Pfizer Inc. and BioNTech as well as that of CureVac NV, Reuters said Friday, citing an EU official it didn’t name. The price it agreed for the Pfizer-BioNTech shot is 15.50 euros ($18.34) per dose, less than what the U.S. is paying, the newswire said.
Wealthy countries block COVID-19 drugs rights waiver at WTO – sources
Supporters of the waiver say existing intellectual property (IP) rules create barriers on access to affordable medicines and vaccines and they want restrictions to be eased, as they were during the AIDS epidemic.